BACKGROUND AND OBJECTIVE: Brain disorder diagnosis and prediction remain challenging because neuroimaging, electrophysiological, behavioral, and multimodal data are high-dimensional, noisy, heterogeneous, and limited by small clinical cohorts. This systematic review synthesised applications of quantum artificial intelligence (QAI) for brain disorder diagnosis, prediction, detection, and monitoring. METHODS: Following PRISMA guidelines, studies published from 2016 to 13 January 2026 were retrieved from Scopus, Web of Science, and IEEE Xplore. After screening, 36 studies met the eligibility criteria and were qualitatively analysed according to disorder category, data modality, QAI method, implementation setting, validation strategy, and performance. RESULTS: At the broader disease-group level, neurodegenerative disorders were the most frequently investigated, followed by mental health and psychiatric disorders. At the individual level, Parkinson's disease and schizophrenia were the leading applications, followed by depression, anxiety, Alzheimer's disease, and stress-related tasks. MRI-based modalities were the most frequently used data source, followed by multimodal data and EEG. Methodologically, primary QAI approaches were dominated by quantum neural and QDL architectures, followed by quantum-inspired optimization or feature-selection methods and quantum-kernel/conventional QML classifiers. Qiskit/IBM Quantum and PennyLane were the most frequently reported quantum software frameworks. However, most studies relied on simulators, classical quantum-inspired implementations, or unclear implementation settings, with limited real-hardware evaluation. CONCLUSIONS: QAI shows emerging potential for brain disorder analysis, particularly through hybrid quantum-classical learning, quantum neural architectures, quantum-kernel methods, and quantum-inspired optimization. Nevertheless, current evidence remains preliminary and requires larger datasets, subject-level and external validation, fair classical benchmarking, noise-resilient circuits, real quantum hardware evaluation, explainability, and clinical validation.
BACKGROUND AND OBJECTIVE: Brain disorder diagnosis and prediction remain challenging because neuroimaging, electrophysiological, behavioral, and multimodal data are high-dimensional, noisy, heterogeneous, and limited by small clinical cohorts. This systematic review synthesised applications of quantum artificial intelligence (QAI) for brain disorder diagnosis, prediction, detection, and monitoring. METHODS: Following PRISMA guidelines, studies published from 2016 to 13 January 2026 were retrieved from Scopus, Web of Science, and IEEE Xplore. After screening, 36 studies met the eligibility criteria and were qualitatively analysed according to disorder category, data modality, QAI method, implementation setting, validation strategy, and performance. RESULTS: At the broader disease-group level, neurodegenerative disorders were the most frequently investigated, followed by mental health and psychiatric disorders. At the individual level, Parkinson's disease and schizophrenia were the leading applications, followed by depression, anxiety, Alzheimer's disease, and stress-related tasks. MRI-based modalities were the most frequently used data source, followed by multimodal data and EEG. Methodologically, primary QAI approaches were dominated by quantum neural and QDL architectures, followed by quantum-inspired optimization or feature-selection methods and quantum-kernel/conventional QML classifiers. Qiskit/IBM Quantum and PennyLane were the most frequently reported quantum software frameworks. However, most studies relied on simulators, classical quantum-inspired implementations, or unclear implementation settings, with limited real-hardware evaluation. CONCLUSIONS: QAI shows emerging potential for brain disorder analysis, particularly through hybrid quantum-classical learning, quantum neural architectures, quantum-kernel methods, and quantum-inspired optimization. Nevertheless, current evidence remains preliminary and requires larger datasets, subject-level and external validation, fair classical benchmarking, noise-resilient circuits, real quantum hardware evaluation, explainability, and clinical validation.
A JBI scoping review of quantum artificial intelligence (QAI) methods applied to neuropsychiatric disorders in healthcare and clinical research settings. The review maps QAI algorithms, hardware implementations, and clinical data modalities across conditions including depression, schizophrenia, bipolar disorder, dementia, epilepsy, ASD, ADHD, PTSD, and anxiety disorders. A secondary aim is to characterize structural barriers to translational integration across technical, data, clinical/operational, regulatory/ethical, and neuropsychiatric domain dimensions. Reporting follows PRISMA-ScR (Tricco et al. 2018). Seven databases will be searched (PubMed/MEDLINE, Embase, IEEE Xplore, ACM Digital Library, Scopus, Web of Science, PsycINFO). Date range: January 2016 to present.
Parkinson's disease is a progressive neurological disorder.Speech, gait, and handwriting often change before a specialist can confirm the diagnosis.Clinics still depend heavily on observation, which takes time and can vary between doctors.Recent papers combine machine learning with quantum and hybrid quantum-classical models to improve screening from multimodal data.This review covers eight studies (2023-2026) that use Quantum LSTM, variational quantum circuits, quantum neural networks, quantum-inspired SVM, and metaheuristic feature selection for PD detection.We note which biomarkers each work uses, the accuracy or AUC reported, and repeated limits: simulation-only runs, public datasets, and weak clinical follow-up.A shared pipeline is summarised.Quantum AI may help earlier detection, but surveyed systems are not yet ready for routine hospital use without hardware noise tests and longer patient studies.
Background Artificial Intelligence (AI) incorporation within healthcare applications has significantly helped in the improvement of healthcare diagnostics, patient forecasting, and clinical decision-making. The steady growing of medical data in terms of quantity, quality, and dimension poses more significant problems for traditional AI methods in terms of size, time, and computational efficiency. However, classical machine learning models often struggle with high-dimensional, imbalanced, and heterogeneous medical datasets, which limits their scalability and generalizability. The Quantum Artificial Intelligence (QAI) model, which combines quantum computing and machine learning in a complementary way, has emerged as one of the main trends to defeat these problems. This complementary approach is gaining more popularity, with the most advanced work being developed in this area, as it offers a fundamental explanation of current complexities and the underlying principles and their applications. Methodology This paper begins with the basic concepts of quantum computing and where it overlaps with AI. It then moves to a comparative approach, discussing various quantum machine learning algorithms such as quantum support vector machines, quantum neural networks, and variational quantum circuits. A comparative evaluation of quantum support vector machine, variational quantum classifier, quantum neural network, quantum K-means, and quantum Boltzmann machine is conducted using the Pima Indians Diabetes dataset to assess model behaviour and performance under standard metrics. Further detail is provided on the theoretical and practical implications of QAI in medical imaging, genomics, electronic health records, and drug discovery. Additionally, this paper examines platforms, tools, and quantum hardware used for QAI research, and discusses unique challenges currently faced in quantum technology. Results Unlike prior surveys that primarily provide conceptual overviews, this paper uniquely combines a comprehensive review with practical benchmarking of multiple quantum machine learning models on a benchmark medical dataset. This provides comparative insights into algorithmic performance under real-world constraints, particularly in relation to high-dimensional medical data, genomic data, electronic health records with large number of clinical attributes, radiology images, etc. In this study, dimensionality arises from multivariate clinical features encoded into quantum feature maps and the limitations of current quantum systems. Conclusion This paper aims to serve as a starting point for researchers and practitioners interested in the potential of quantum-enhanced AI to transform health data analytics. By identifying current limitations, evaluating the performance of emerging quantum machine learning approaches, and outlining gaps in the literature, the paper highlights future research directions necessary to advance QAI in healthcare. Overall, the findings outline both the potential and practical constraints of quantum models, offering a foundation for future work toward scalable, clinically applicable QAI solutions.
Quantum Machine Learning (QML) has emerged as a promising interdisciplinary paradigm that integrates quantum computing and machine learning to address limitations of classical approaches in processing complex high-dimensional heterogeneous and imbalanced medical data. This study presents a systematic literature review of QML applications in healthcare based on 94 primary studies published between 2020 and April 2025. The review follows Kitchenham’s guidelines and the PRISMA framework to ensure rigor transparency and reproducibility. Seven research questions were formulated to examine publication trends sources datasets topics quantum model categories algorithms methods and evaluation metrics. Findings reveal a sharp increase in publication activity after 2023 indicating growing academic interest in healthcare-oriented QML. Medical imaging datasets were most frequently used followed by signal-based and tabular datasets with 86.5% of studies relying on public data. Hybrid classical-quantum approaches including CNN-QSVM Quantum Neural Networks and Variational Quantum Classifiers were dominant because they combine classical feature extraction with quantum-enhanced learning. However most studies were conducted in simulation environments rather than real hardware reflecting NISQ limitations including noise decoherence limited qubits and circuit depth constraints. Many results used small curated or imbalanced datasets raising concerns regarding generalizability reproducibility and clinical validity. Although numerous studies reported high accuracy standardized evaluation protocols external validation and uncertainty assessment remain limited. Overall QML in healthcare remains exploratory with substantial potential but significant barriers. This review highlights progress gaps and future directions emphasizing clinically representative datasets robust benchmarking interpretable noise-resilient models and real-hardware implementation to support trustworthy deployment in healthcare systems worldwide settings today.
Mental health disorders represent a growing global healthcare challenge affecting hundreds of millions of people worldwide. Major depressive disorder (MDD), anxiety disorders, post-traumatic stress disorder (PTSD), and Alzheimer’s disease place huge pressure on medical systems. A central challenge is early detection, which remains difficult due to the complexity of symptoms related to these diseases. Delayed diagnosis is also due to limited access to specialists and the multimodal complexity of relevant biomarkers, clinical assessments, neuroimaging, physiological signals, and behavioral data. Recent developments in artificial intelligence (AI) have demonstrated promising results in improving diagnostic support. However, classical AI still struggles to model high-dimensional correlations and inherent uncertainties that are common to cognitive-emotional data. This chapter explores quantum machine learning (QML) as a transformative paradigm to overcome these limitations. We provide a comprehensive overview of foundational QML architectures and evaluate its suitability for processing diverse healthcare data such as neuroimaging, wearable sensor inputs, and electronic health records (EHRs). We propose a new conceptual framework for a quantum-enabled clinical decision support system that integrates multimodal feature extraction. Taking into consideration the sensitivity of psychiatric data, we critically examine security imperatives that include federated learning and post-quantum privacy protection. This chapter aims to provide researchers and practitioners with a comprehensive perspective on how quantum computing (QC) may contribute to future intelligent mental healthcare.
Abstract The convergence of quantum computing and medical image analysis has emerged as a promising frontier for advancing diagnostic intelligence beyond the limits of classical machine learning. Recent developments in quantum hardware and quantum machine learning (QML) algorithms have stimulated growing interest in their potential to enhance complex medical imaging tasks, including disease classification, image segmentation, and clinical decision support (Wei et al., 2023; Ullah and Garcia-Zapirain, 2024). This study presents a comprehensive review and synthesis of state-of-the-art QML methodologies applied to medical imaging, systematically examining both theoretical foundations and empirical implementations. We analyze quantum-based and hybrid quantum–classical models employed across modalities such as MRI, CT, X-ray, and histopathological imaging, with particular attention to classification accuracy, computational efficiency, and diagnostic robustness (Maheshwari et al., 2022; ElBedoui et al., 2025). Our findings reveal clear trends indicating that hybrid quantum–classical approaches currently dominate practical applications, consistently outperforming purely classical baselines in select low-dimensional and domain-specific diagnostic tasks. Performance gains are most evident in feature-rich yet data-constrained scenarios, where quantum kernels and variational circuits demonstrate enhanced representational capacity (Ajlouni et al., 2023; Landman et al., 2022). However, these advantages remain context-dependent and sensitive to noise, circuit depth, and encoding strategies. Overall, QML holds significant promise for improving medical image-based diagnosis, but its widespread clinical adoption is constrained by hardware scalability, limited qubit coherence, and unresolved data encoding challenges. Addressing these limitations will be critical for translating QML from experimental feasibility to routine medical practice (Marengo and Santamato, 2025; Rawas and AlSaeed, 2026).